Registered entities
Afferent Pharmaceuticals, Inc.
Reg. No. 271116683United States
Innovation
7 patent families (7 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 581 times.
| Year | Filings |
|---|---|
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 7 |
| 2019 | 7 |
| 2020 | 5 |
| 2021 | 6 |
| 2022 | 7 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 1 |
Investor mix
11 investors on record; lead investors include New Leaf Venture Partners, Third Rock Ventures, Domain Associates, Pappas Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 45% |
| Private equity | 1 | 9% |
| Other / undisclosed | 5 | 45% |